[go: up one dir, main page]

Discussion about this post

User's avatar
Saul's avatar

The pieces on Danaher & Bayer were particularly interesting. Change management is generally very challenging to implement. In Bayer’s case, you couldn’t just run the typical PE playbook of reducing costs/management as they need to retain the creative component of the company. In many ways the company exemplifies the challenges of being a mid-size player (especially in pharma)-too big to be agile and too small to achieve real scale (plus the Monsanto overhang).

No posts

Ready for more?

    This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts